Literature DB >> 16794015

Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone.

Koshi Hashimoto1, Masanobu Yamada, Shunichi Matsumoto, Tsuyoshi Monden, Teturou Satoh, Masatomo Mori.   

Abstract

Sterol regulatory element-binding protein (SREBP)-1c is a key regulator of fatty acid metabolism and plays a pivotal role in the transcriptional regulation of different lipogenic genes mediating lipid synthesis. In previous studies, the regulation of SREBP-1c mRNA levels by thyroid hormone has remained controversial. In this study, we examined whether T3 regulates the mouse SREBP-1c mRNA expression. We found that T3 negatively regulates the mouse SREBP-1c gene expression in the liver, as shown by ribonuclease protection assays and real-time quantitative RT-PCR. Promoter analysis with luciferase assays using HepG2 and Hepa1-6 cells revealed that T3 negatively regulates the mouse SREBP-1c gene promoter (-574 to +42) and that Site2 (GCCTGACAGGTGAAATCGGC) located around the transcriptional start site is responsible for the negative regulation by T3. Gel shift assays showed that retinoid X receptor-alpha/thyroid hormone receptor-beta heterodimer bound to Site2, but retinoid X receptor-alpha/liver X receptor- heterodimer could not bind to the site. In vivo chromatin immunoprecipitation assays demonstrated that T3 induced thyroid hormone receptor-beta recruitment to Site2. Thus, we demonstrated that mouse SREBP-1c mRNA is down-regulated by T3 in vivo and that T3 negatively regulates mouse SREBP-1c gene transcription via a novel negative thyroid hormone response element: Site2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794015     DOI: 10.1210/en.2006-0116

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  32 in total

1.  Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.

Authors:  Daniel F Vatner; Dirk Weismann; Sara A Beddow; Naoki Kumashiro; Derek M Erion; Xiao-Hui Liao; Gary J Grover; Paul Webb; Kevin J Phillips; Roy E Weiss; Jonathan S Bogan; John Baxter; Gerald I Shulman; Varman T Samuel
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-07       Impact factor: 4.310

Review 2.  Thyroid hormone analogues and derivatives: Actions in fatty liver.

Authors:  Maria Coppola; Daniela Glinni; Maria Moreno; Federica Cioffi; Elena Silvestri; Fernando Goglia
Journal:  World J Hepatol       Date:  2014-03-27

3.  Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.

Authors:  Pragya Sharma; Shalini Thakran; Xiong Deng; Marshall B Elam; Edwards A Park
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

4.  Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Authors:  Mark D Erion; Edward E Cable; Bruce R Ito; Hongjian Jiang; James M Fujitaki; Patricia D Finn; Bao-Hong Zhang; Jinzhao Hou; Serge H Boyer; Paul D van Poelje; David L Linemeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

Review 5.  Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

6.  Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone.

Authors:  Koshi Hashimoto; Emi Ishida; Shunichi Matsumoto; Shuichi Okada; Masanobu Yamada; Teturou Satoh; Tsuyoshi Monden; Masatomo Mori
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

Review 7.  Endocrine and liver interaction: the role of endocrine pathways in NASH.

Authors:  Paola Loria; Lucia Carulli; Marco Bertolotti; Amedeo Lonardo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

8.  Nuclear receptors reverse McGarry's vicious cycle to insulin resistance.

Authors:  David D Moore
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

9.  Thyroid dysfunction, either hyper or hypothyroidism, promotes gallstone formation by different mechanisms.

Authors:  Yong Wang; Xing Yu; Qun-Zi Zhao; Shu Zheng; Wen-Jie Qing; Chun-di Miao; Jaiswal Sanjay
Journal:  J Zhejiang Univ Sci B       Date:  2016-07       Impact factor: 3.066

10.  Adipogenic and energy metabolism gene networks in longissimus lumborum during rapid post-weaning growth in Angus and Angus x Simmental cattle fed high-starch or low-starch diets.

Authors:  Daniel E Graugnard; Paola Piantoni; Massimo Bionaz; Larry L Berger; Dan B Faulkner; Juan J Loor
Journal:  BMC Genomics       Date:  2009-03-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.